ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,122,000 | +131.8% | 91,600 | +116.5% | 0.34% | +148.2% |
Q2 2017 | $484,000 | -36.6% | 42,300 | +15.3% | 0.14% | -44.1% |
Q1 2017 | $763,000 | +19.4% | 36,700 | +88.2% | 0.24% | +3.4% |
Q3 2016 | $639,000 | +160.8% | 19,500 | +99.0% | 0.24% | +189.0% |
Q2 2016 | $245,000 | – | 9,800 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |